Tag Archives: Drug patents

COVID-19 drug and vaccine patents are putting profit before people

The TRIPS waiver enables WTO member states to manufacture and distribute COVID-19 drugs and medical supplies that would normally be protected by patents. (Pixabay) Ronald Labonte, L’Université d’Ottawa/University of Ottawa and Mira Johri, Université de Montréal Since the birth of the World Trade Organization (WTO) in 1995, most member states have had to abide by the Agreement on Trade Related …

Read More »